Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06488716
Title A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7759065 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genentech, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN | AUS

Facility Status City State Zip Country Details
City of Hope Comprehensive Cancer Center RECRUITING Duarte California 91010 United States Details
Tennesse Oncology - NASH - SCRI - PPDS RECRUITING Chattanooga Tennessee 37404-1130 United States Details
St Vincent's Hospital Sydney RECRUITING Darlinghurst New South Wales 2010 Australia Details
Princess Margaret Cancer Centre RECRUITING Toronto Ontario M5G 2MR Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field